drugset / Trial / NCT05871437
Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules
Phase 4
Not yet recruiting
232 enrolled
Fudan University
Huazhong University of Science and Technology · collabLinkDoc Technology (Beijing) Co. Ltd. · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is a prospective, multicenter, randomized controlled clinical trial designed to evaluate the rate of reduction of tumor markers to normal levels in breast cancer patients treated with Huaier granules compared to the control group.
Timeline
- Start
- 2025-09
- Primary completion
- 2026-01
- Completion
- 2028-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huaier Granule | Traditional medicine (herbal / TCM) | 10 g | Oral |